Performance of the XN-2000 WPC channel-flagging to differentiate reactive and neoplastic leukocytosis
-
Peter Schuff-Werner
, Peter Kohlschein
, Aliaksandra Maroz , Joachim Linssen , Katrin Dreißiger and Christine Burstein
Abstract
Background:
The distinction between reactive and neoplastic leukocytes, especially atypical lymphocytes suspected to be reactive or neoplastic, is a particular challenge in automated hematological cell differentiation. The aim of the study was to evaluate the performance of the XN analyzer supplemented with the WPC channel for differentiating between reactive and neoplastic leukocytosis.
Methods:
Blood samples of 253 patients with viral infections, lymphoma or leukemia were analyzed by the Sysmex XN-2000 analyzer equipped with the WPC channel. The results were compared to routine leukocyte differentiation using the routine Sysmex XE-2100 analyzer and automated digital microscopy (DM96). The combined information from standard morphology, immune phenotyping and clinical diagnosis served as a reference.
Results:
The XN WPC channel demonstrated an excellent performance for differentiating neoplastic (AUC=0.933) and reactive leukocytosis (AUC=0.900) as compared to morphological smear examination (AUC=0.949 and AUC=0.968, respectively) or to the differentiation results of our routine hematology analyzer (AUC=0.630 and AUC=0.635, respectively).
Conclusions:
Our data show that the combined WDF/WPC of the Sysmex XN-Series analyzer is advantageous in the automated differentiation of neoplastic and reactive leukocytosis, thus supporting the correct diagnostic decision in the daily laboratory routine.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission. PSW and PK contributed equally to this paper.
Research funding: The study was supported by a grant from Sysmex Europe, Norderstedt, to cover the cost of reagents. Travel costs declared by PSW for participation at scientific meetings were covered in part by Sysmex Europe.
Employment or leadership: AM and JL are full time employees of Sysmex Europe.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Simon MW. The atypical lymphocyte. Int Pediatr 2003;18:20–2.Search in Google Scholar
2. Baurmann H, Bettelheim P, Diem H, Gassmann W, Nebe T. Lymphocyte morphology in the peripheral blood film: proposal of a revised nomenclature and systematics. Lab Med 2011;35:261–70.10.1515/JLM.2011.037etSearch in Google Scholar
3. Zini G, Bain B, Bettelheim P, Cortez J, d’Onofrio G, Faber E, et al. A European consensus report on blood cell identification: terminology utilized and morphological diagnosis concordance among 28 experts from 17 countries within the European LeukemiaNet network WP10, on behalf of the ELN Morphology Faculty. Br J Haematol 2010;151:359–64.10.1111/j.1365-2141.2010.08366.xSearch in Google Scholar PubMed
4. George TI. Malignant or benign leukocytosis. In: Hematology Education: the education program for annual congress of the European Hematology Association, The Hague, Netherlands: European Hematology Association. 2012;2:475–84.10.1182/asheducation.V2012.1.475.3798515Search in Google Scholar
5. van der Meer W, Scott CS, de Keijzer MH. Automated flagging influences the inconsistency and bias of band cell and atypical lymphocyte morphological differentials. Clin Chem Lab Med 2004;42:371–7.Search in Google Scholar
6. Barnes PW, McFadden SL, Machin SJ, Simson E. The international consensus group for hematology review: suggested criteria for action following automated CBC and WBC differential analysis. Lab Hematol 2005;11:83–90.10.1532/LH96.05019Search in Google Scholar PubMed
7. Briggs C, Longair I, Kumar P, Singh D, Machin SJ. Performance evaluation of the Sysmex haematology XN modular system. J Clin Pathol 2012;65:1024–30.10.1136/jclinpath-2012-200930Search in Google Scholar PubMed
8. Jones AS, Tailor H, Liesner R, Machin SJ, Briggs CJ. The value of the white precursor cell channel (WPC) on the Sysmex XN-1000 analyser in a specialist paediatric hospital. J Clin Pathol 2015;68:161–5.10.1136/jclinpath-2014-202640Search in Google Scholar PubMed
9. Bruegel M, Nagel D, Funk M, Fuhrmann P, Zander J, Teupser D. Comparison of five automated hematology analyzers in a university hospital setting: Abbott Cell-Dyn Sapphire, Beckman Coulter DxH 800, Siemens Advia 2120i, Sysmex XE-2100, and Sysmex XN-2000. Clin Chem Lab Med 2015;53:1057–71.10.1515/cclm-2014-0945Search in Google Scholar PubMed
10. Seo J, Lee S, Kim S. Performance evaluation of the new hematology analyzer Sysmex XN-series. Int J Lab Hematol 2015;37:155–64.10.1111/ijlh.12254Search in Google Scholar PubMed
11. World Health Organization. International classification of diseases and delated health problems, 10th edition. 2010 [cited 2014]. Available from: http://www.who.int/classifications/icd/ICD10Volume2_en_2010.pdf.Search in Google Scholar
12. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, editors. WHO classification of tumours of haematopoietic and lymphoid tissues, 4th ed. IARC: Lyon, 2008:439.Search in Google Scholar
13. Ruzicka K, Veitl M, Thalhammer-Scherrer R, Schwarzinger I. The new hematology analyzer Sysmex XE-2100: performance evaluation of a novel white blood cell differential technology. Arch Pathol Lab Med 2001;125:391–6.10.5858/2001-125-0391-TNHASXSearch in Google Scholar PubMed
14. Takagi Y, Kono M, Yamamoto S, Wada A, Morikawa T. Comparison of optical data from flow cytometry and microscopy of leukocytes after exposure to specific reagents. Microscopy (Oxf) 2015;64:305–10.10.1093/jmicro/dfv023Search in Google Scholar PubMed
15. Gottfried EL. Lipids of human leukocytes: relation to celltype. J Lipid Res 1967;8:321–7.10.1016/S0022-2275(20)39561-4Search in Google Scholar
16. Kuliszkiewicz-Janus M, Tuz MA, Kielbinski M, Jazwiec B, Niedoba J, Baczynski S. 31P MRS analysis of the phospholipid composition of the peripheral blood mononuclear cells (PBMC) and bone marrow mononuclear cells (BMMC) of patients with acute leukemia (AL). Cell Mol Biol Lett 2009;14:35–45.10.2478/s11658-008-0032-7Search in Google Scholar PubMed PubMed Central
17. El Kirat K, Morandat S. Cholesterol modulation of membrane resistance to Triton X-100 explored by atomic force microscopy. Biochim Biophys Acta 2007;1768:2300–9.10.1016/j.bbamem.2007.05.006Search in Google Scholar PubMed
18. Kawauchi S, Kono M, Takagi Y, Wada A, Morikawa T. The positions of normal leukocytes on the scattergram of the newly developed abnormal cell-detection channel of the XN-Series multi-parameter automated hematology analyzers. Sysmex J Int 2013;23:1–9.Search in Google Scholar
©2016 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Editorials
- The Theranos phenomenon, scientific transparency and freedom of speech
- Holotranscobalamin: in the middle of difficultly lies opportunity
- Review
- Laboratory and clinical risk assessment to treat myelodysplatic syndromes
- Mini Review
- Quantitative nucleic acid amplification by digital PCR for clinical viral diagnostics
- Genetics and Molecular Diagnostics
- Hybrid minigene splicing assay verified the pathogenicity of a novel splice site variant in the dystrophin gene of a Chinese patient with typical Duchenne muscular dystrophy phenotype
- General Clinical Chemistry and Laboratory Medicine
- Prospective validation of an automated chemiluminescence-based assay of renin and aldosterone for the work-up of arterial hypertension
- Sex steroid hormone stability in serum tubes with and without separator gels
- Reduced absorption and enhanced synthesis of cholesterol in patients with cystic fibrosis: a preliminary study of plasma sterols
- An International Standard for holotranscobalamin (holoTC): international collaborative study to assign a holoTC value to the International Standard for vitamin B12 and serum folate
- A technical and clinical evaluation of a new assay for inhibin A and its use in second trimester Down syndrome screening
- Investigation on the ability of first trimester glycodelin and angiopoietin-2 to predict small-for-gestational age pregnancies at delivery
- Plasma total C-terminal agrin fragment (tCAF) as a marker for kidney function in patients with chronic kidney disease
- Hematology and Coagulation
- Thirty-minutes’ exposure to smartphone call triggers neutrophil activation in vitro
- Performance of the XN-2000 WPC channel-flagging to differentiate reactive and neoplastic leukocytosis
- Differences in lupus anticoagulant final conclusion through clotting time or Rosner index for mixing test interpretation
- Reference Values and Biological Variations
- Derivation of level-specific reference change values (RCV) from a health screening database and optimization of their thresholds based on clinical utility
- Cancer Diagnosis
- BRAF analysis before surgery for papillary thyroid carcinoma: correlation with clinicopathological features and prognosis in a single-institution prospective experience
- Letters to the Editor
- Significant increase of serum prostate-specific antigen after exercise
- Serum delipidation but not high-speed centrifugation is effective in clearing lipemia interference in serum lipase activity measurement
- A relationship between absolute monocyte count and C-reactive protein in patients with migraine undergoing no pharmacological therapy
- Validation of the “Vacutainer® urinalysis preservative plus urine tube” for the determination of albumin and protein
- Performance evaluation of a novel automated HIV Ag/Ab chemiluminescence immunoassay
- SLC26A4 genotypes associated with enlarged vestibular aqueduct malformation in south Italian children with sensorineural hearing loss
- Is cystatin C level altered in women with polycystic ovary syndrome?
- Venous thromboembolism in a patient with persistent inhibitor to coagulation factor V – a case report
- Free light chains nephelometric assay: human urine stability in different storage conditions
- Comparing the viscoelastomeric fibrin polymerization assays FIBTEM® (ROTEM) vs. Functional Fibrinogen® (TEG): or why is a higher threshold for fibrinogen substitution better than a lower one?
- Reply to: Comparing the visco-elastomeric fibrin polymerization assays FIBTEM® (ROTEM) vs. Functional Fibrinogen® (TEG): or why is a higher threshold for fibrinogen substitution better than a lower one? By Schöchl et al.
- Congress Abstracts
- 5th Slovenian Congress of Clinical Chemistry and Laboratory Medicine
Articles in the same Issue
- Frontmatter
- Editorials
- The Theranos phenomenon, scientific transparency and freedom of speech
- Holotranscobalamin: in the middle of difficultly lies opportunity
- Review
- Laboratory and clinical risk assessment to treat myelodysplatic syndromes
- Mini Review
- Quantitative nucleic acid amplification by digital PCR for clinical viral diagnostics
- Genetics and Molecular Diagnostics
- Hybrid minigene splicing assay verified the pathogenicity of a novel splice site variant in the dystrophin gene of a Chinese patient with typical Duchenne muscular dystrophy phenotype
- General Clinical Chemistry and Laboratory Medicine
- Prospective validation of an automated chemiluminescence-based assay of renin and aldosterone for the work-up of arterial hypertension
- Sex steroid hormone stability in serum tubes with and without separator gels
- Reduced absorption and enhanced synthesis of cholesterol in patients with cystic fibrosis: a preliminary study of plasma sterols
- An International Standard for holotranscobalamin (holoTC): international collaborative study to assign a holoTC value to the International Standard for vitamin B12 and serum folate
- A technical and clinical evaluation of a new assay for inhibin A and its use in second trimester Down syndrome screening
- Investigation on the ability of first trimester glycodelin and angiopoietin-2 to predict small-for-gestational age pregnancies at delivery
- Plasma total C-terminal agrin fragment (tCAF) as a marker for kidney function in patients with chronic kidney disease
- Hematology and Coagulation
- Thirty-minutes’ exposure to smartphone call triggers neutrophil activation in vitro
- Performance of the XN-2000 WPC channel-flagging to differentiate reactive and neoplastic leukocytosis
- Differences in lupus anticoagulant final conclusion through clotting time or Rosner index for mixing test interpretation
- Reference Values and Biological Variations
- Derivation of level-specific reference change values (RCV) from a health screening database and optimization of their thresholds based on clinical utility
- Cancer Diagnosis
- BRAF analysis before surgery for papillary thyroid carcinoma: correlation with clinicopathological features and prognosis in a single-institution prospective experience
- Letters to the Editor
- Significant increase of serum prostate-specific antigen after exercise
- Serum delipidation but not high-speed centrifugation is effective in clearing lipemia interference in serum lipase activity measurement
- A relationship between absolute monocyte count and C-reactive protein in patients with migraine undergoing no pharmacological therapy
- Validation of the “Vacutainer® urinalysis preservative plus urine tube” for the determination of albumin and protein
- Performance evaluation of a novel automated HIV Ag/Ab chemiluminescence immunoassay
- SLC26A4 genotypes associated with enlarged vestibular aqueduct malformation in south Italian children with sensorineural hearing loss
- Is cystatin C level altered in women with polycystic ovary syndrome?
- Venous thromboembolism in a patient with persistent inhibitor to coagulation factor V – a case report
- Free light chains nephelometric assay: human urine stability in different storage conditions
- Comparing the viscoelastomeric fibrin polymerization assays FIBTEM® (ROTEM) vs. Functional Fibrinogen® (TEG): or why is a higher threshold for fibrinogen substitution better than a lower one?
- Reply to: Comparing the visco-elastomeric fibrin polymerization assays FIBTEM® (ROTEM) vs. Functional Fibrinogen® (TEG): or why is a higher threshold for fibrinogen substitution better than a lower one? By Schöchl et al.
- Congress Abstracts
- 5th Slovenian Congress of Clinical Chemistry and Laboratory Medicine